Dynacare Laboratories Test Changes

Similar documents
EDUCATIONAL COMMENTARY rd TEST EVENT Chemistry Urine Drug Testing

INTERPATH LABORATORY, INC. TEST UPDATES

Tests that have had changes to the method/ CPT code, units of measurement, scope of analysis, reference comments, or specimen requirements.

Urine Drug Testing Methods 3-5

DRUG-CONJUGATES The drug buprenorphine is conjugated to protein and immobilized as a line on a membrane at the BUP location labeled on the device.

Urine drug testing it s not always crystal clear

DRUGS OF ABUSE

PRINCIPLE REF ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

Opiates Rapid Test. Cat. No.:DTS137 Pkg.Size:50T. Intended use. General Description. Principle Of The Test. Reagents And Materials Provided

Tests that have had changes to the method/ CPT code, units of measurement, scope of analysis, reference comments, or specimen requirements.

Test Definition: PCDSO Pain Clinic Drug Screen, Urine

Urine Drug Testing to Monitor Opioid Use In Managing Chronic Pain

Tests that have had changes to the method/ CPT code, units of measurement, scope of analysis, reference comments, or specimen requirements.

Clinical Chemistry (CHE 221)

NeoSal Oral Fluid Collection System Solutions for Forensic Drug Detection

Review the following alphabetical listing of our lab test catalog for each of our offered tests. Each page has at least the following elements:

Test Definition: PDSOX Pain Clinic Drug Screen, Chain of Custody, Urine

Aerobic Wound Culture and Stain

25-Hydroxy Vitamin D TOTAL (25HD) on Liaison XL

Effective Date: Approved by: Laboratory Executive Director, Ed Hughes (electronic signature)

Drug Screening: Things You Need to Know

Laboratory Testing to Support Pain Management: Methods, Concepts and Case Studies

Welcome! Supreme Court of Ohio Specialized Dockets Conference. October 23-24, 2017

September HCMC Toxicology Transition: Additional information and Frequently Asked Questions

OP2 PRINCIPLE REF ANNUAL REVIEW Reviewed by: Date. Date INTENDED USE

Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective

Pain Medication Management Program Supports Patient Outcomes and Adherence

Pain Medication Management Program Monitors Patient Compliance

Frequently Asked Questions: Opiate Dependency and Methadone Maintenance Treatment program follow-up

Dynacare Laboratories

Conflict of Interest Disclosure

Reference Range: Age/sex dependent; appropriate normals provided with result Analytical Time: 4 hours Day(s) Test Set Up: Daily CPT Code: 84100

Cutoff levels for hydrocodone in a blood test

SERVICE SCHEDULE, FEES & GUIDELINES FOR SAMPLE SHIPMENT

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

Oxymorphone Distribution in Biological Matrices: A Collection of Case Studies

High-Throughput Quantitative LC-MS/MS Analysis of 6 Opiates and 14 Benzodiazepines in Urine

March Monthly Update, Quest Diagnostics Nichols Institute, Valencia

How will tylenol 3 show up in a drug test

Using Liquid Chromatography Tandem Mass Spectrometry Urine Drug Testing to Identify Licit and Illicit Drug-Use in a Community-based Patient Population

Forensic Toxicology Scope of Testing and Detection Limits

In-Common Laboratories

Fast and easy separation of 23 drugs of abuse. including high, stable resolution of isobaric opioids from human urine by UHPLC-MS/MS

October Courier Service on Holidays There will be no courier service Thursday, Dec. 24th, 2011.

HML Update. Summer 2009 Volume 15, No. 3. Keeping Our Clients Informed Questions or Comments: Call

Laboratory Service Report

Lyndsey Knoy, D-ABFT-FT Forensic Scientist Washington State Toxicology Laboratory.

Monday-Friday: tested as required

One of These Tests is Not Like the Other: Comparative effectiveness, cost-effectiveness and utilization guidance in pain management testing

QuickTox Drug Screen Dipcard (with and without Adulteration Tests)

3/8/2018. Reasons for Doing UDT. UDT: A Tool in Risk Assessment. Faculty/Presenter Disclosure. Urine Drug Testing in Chronic Pain Management

High Throughput Extraction of Opiates from Urine and Analysis by GC/MS or LC/MS/MS)

Patient-Centered Urine Drug Testing. Douglas Gourlay, MD, MSc, FRCPC, FASAM

1/27/ New Release, Quest Diagnostics Nichols Institute, Valencia

OraSure Technologies, Inc. 150 Webster Street, Bethlehem, PA Phone: (USA) Fax:


QuickTox Drug Screen Dipcard (with and without Adulteration Tests)

Controlled Substance Monitoring in the Age of the Opioid Epidemic


Responding to the Opioid Addiction Epidemic

Quantitative Analysis of Opiates in Urine Using RRHT LC/MS/MS. Application. Authors. Introduction. Abstract. Forensics

Laboratory Test Result Reporting and Inquiry Procedures

December Metanephrines, Fractionated, Free, Plasma Plasminogen Activator Inhibitor Type 1 Stool Cultures and Sensitivities

Authors. Abstract. Introduction. Forensics

METABOLITE TEST REQUISITION FORM SPECIMEN INFORMATION. Specimen Date: Time: ADDITIONAL INFORMATION

Urine Drug Screening: The Essentials of Interpretation

Testing for Controlled Substances

Tests recently added to the NMS Labs test menu. New Tests are effective immediately.

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

January Testing Delays and Spurious Results Caused by Improper Specimen Collection

Determination of Opiates and Metabolites in Blood Using Electrospray LC/MS. Application Note

Recent Advances in the Analysis of Ethanol in Saliva: Evaluation of the QED Device

The Drug Testing Process. Employer or Practice

Copyright 2013 Crosscutting Concepts, LLC. All Rights Reserved.

Urine Drug Testing. Methadone/Buprenorphine 101 Workshop. Ron Joe, MD, DABAM December 10, 2016

METABOLITE TEST REQUISITION FORM

UNDERSTANDING. Permanent Birth Control for Men

COLLECTION TUBES FOR PHLEBOTOMY

Chapter 17 Worksheet Code It

How does oxycodone show up on a drug test

OPIOIDS. Testing and Interpretation

Urine Testing for Opioids

Flush hydrocodone out of system for drug test

DAU. Scheme Description. Drugs of Abuse in Urine Proficiency Testing Scheme

Patient Preparation Unique patient preparation requirements are listed under each test in the Test Directory.

A Toxicologists View of Addiction

URINE DRUG TOXICOLOGY

A Practical Method for the Solid Phase Extraction and GC/MS Analysis of 7 Opiates in Urine

Gold Standard for Urine Drug Testin Urine Drug Testing Why U rine? Urine?

Protocol for Processing parasites

ONLINE DAT II Results matter.

Anti-FceR (CU Index) Antibody

Applications of High Resolution Mass Spectrometry in Forensic Toxicology. Patrick Kyle, PhD.

What Your Drug Test Really Means. Krista Beiermann, RN, OHS Occupational Health Services, Columbus Hospital


Does ultram show up as an opiate

DrugConfirm Advanced Urine Dip Cards.

Trust but verify is good advice

Rapid Spot Tests for Detecting the Presence of Adulterants in Urine Specimens Submitted for Drug Testing

Prepared by Date Adopted Supersedes Procedure # Review Date Revision Date Signature. Distributed to # of Copies Distributed to # of Copies

Transcription:

CHROMIUM CHROMIUM CHROM CHROM 82495 82495 3508250 3508250 Plasma/ Whole blood 3.0 ml 3.0 ml Royal Blue Top (EDTA) Tube Royal Blue Top (EDTA) Tube Separate plasma/serum within 45 minutes of collection, and transfer to a plastic transport tube. Submit original unopened tube.in the nocturnal total parenteral nutrition patient, the sample will be drawn fasting in the afternoon, before the nocturnal solution is started for the evening Prep Prep Submit original unopened tube Inductively-coupled plasma-mass spectrometry (ICP-MS) Inductively-coupled plasma-mass spectrometry (ICP-MS) Environmental exposure: 0.1-2.1 µg/l Environmental exposure: 0.1-2.1 µg/l Test used to monitor industrial exposure to chromium. This test is not intended to monitor chromium levels in diabetic patients or in patients with suspected chromium deficiencies. Test used to monitor industrial exposure to chromium. This test is not intended to monitor chromium levels in diabetic patients or in patients with suspected chromium deficiencies. Changed ructions Changed

ETHOSUXIMIDE ETHOSUXIMIDE ETHOSUX ETHOSUX 80168 80168 3507675 3507675 Zarontin Zarontin 1.0 ml 1.0 ml Red Top Tube. Do NOT use SSTs. Red Top Tube. Do NOT use SSTs. Oral Peak is 2-4 hours after dose. Oral Trough is immediately prior to next dose. Oral Peak is 2-4 hours after dose. Oral Trough is immediately prior to next dose. Prep to a Plastic Transport Tube. Prep to a Plastic Transport Tube. Immunoassay Immunoassay 40-100 µg/ml; Potentially toxic: >100 µg/ml Critical >200 ug/ml 40-100 µg/ml; Potentially toxic: >100 µg/ml Changed

ETHYLENE GLYCOL ETHYLENE GLYCOL ETHY GLYC ETHY GLYC 82693 82693 8000630 8000630 2.0 ml 2.0 ml Red Top Tube or Dark Green Tube. DO NOT use SST. Red Top Tube. DO NOT use SST. Prep Centrifuge* and transfer to a Plastic Transport Tube Prep Centrifuge* and transfer to a Plastic Transport Tube d d Gas Liquid Chromatography Gas Liquid Chromatography Negative; Toxic Level: 10 mg/dl Negative; Toxic Level: 10 mg/dl Ethylene glycol is the basic ingredient in automobile antifreeze. Ethylene glycol is the basic ingredient in automobile antifreeze. Changed

HIV PHENOSENSE COMPREHENSIVE HIV PHENO Prep 87903, 87904 x11 3505852 Plasma 5.0 ml 2 Lavender Top (EDTA) Tubes Centrifuge* within 2 hours of collection and immediately transfer to a Purple Screw Cap Tube. FREEZE IMMEDIATELY and maintain frozen until tested. Freeze Frozen Direct measurement of HIV drug susceptibility Descriptive Report One time per week Viral load of 1000 copies or more required for testing. Submit separate frozen samples when requesting multiple tests on the same specimen. HIV PHENOSENSE COMPREHENSIVE HIV PHENO Prep 87903, 87904 x10 3505852 Plasma 5.0 ml 2 Lavender Top (EDTA) Tubes Centrifuge* within 2 hours of collection and immediately transfer to a Purple Screw Cap Tube. FREEZE IMMEDIATELY and maintain frozen until tested. Freeze Frozen Direct measurement of HIV drug susceptibility Descriptive Report One time per week Viral load of 1000 copies or more required for testing. Submit separate frozen samples when requesting multiple tests on the same specimen. Changed

MALARIA SMEAR MALARIA SMEAR MALAR SM MALAR SM 87207 87207 2000690 2000690 Whole Blood Whole Blood 4.0 ml 4.0 ml Lavender Top (EDTA) Tube Lavender Top (EDTA) Tube should be collected at times of chill or fever. Invert immediately and mix with anticoagulant 8-10 times. In cases with travel history suggestive of malarial exposure, contact Dynacare laboratories to arrange for a STAT courier. s should be received in laboratory without delay to minimize potential false-negative results due to cell lysis. should be collected at times of chill or fever. Invert immediately and mix with anticoagulant 8-10 times. Prep Do NOT centrifuge. In cases with travel history suggestive of malarial exposure, contact Dynacare laboratories to arrange for a STAT courier. s should be received in laboratory without delay to minimize potential false-negative results due to cell lysis. Prep Do NOT centrifuge., preferred or, preferred or Manual, Microscopic examination of Wright's/Giemsa Stained Smears. Manual, Microscopic examination of Wright's/Giemsa Stained Smears. No Malarial Parasites seen No Malarial Parasites seen Smears positive for Malarial Parasites are reviewed by a Pathologist for speciation. Smears positive for Malarial Parasites are reviewed by a Pathologist for speciation. ructions Changed Prep Changed

OPIATES Qualitative, Urine U OPIATES Prep 82101 8000679 Codeine, Dihydrocodeine, Ethyl morphine, Heroin (diacetylmorphine), Hydrocodone, Hydromorphone, 6-monoacetylmorphine (6- MAM), Morphine-3-glucuronide,Morphine, Thebaine Heroin Urine (Random) 5.0 ml Plastic Urine Immunoassay No reference ranges are defined for drugs of abuse testing. Expected value: Negative Results <300 ng/ml are reported out as Negative OPIATES Qualitative, Urine U OPIATES Prep 82101 8000679 Codeine, Dihydrocodeine, Ethyl morphine, Heroin (diacetylmorphine), Hydrocodone, Hydromorphone, 6-monoacetylmorphine (6- MAM), Morphine-3-glucuronide, Thebaine Heroin Urine (Random) 5.0 ml Plastic Urine Immunoassay No reference ranges are defined for drugs of abuse testing. Expected value: Negative Results <300 ng/ml are reported out as Negative Results 300 ng/ml are reported out as Positive Results 300 ng/ml are reported out as Positive This is only a screening test. Positive results should be confirmed by an alternate method. This test does not detect oxycodone and/or oxymorphone. For oxycodone and/or oxymorphone screening, order Urine Oxycodone Screen (U OXY SCR, 8000708). This is only a screening test. Positive results should be confirmed by an alternate method. This test does not detect oxycodone and/or oxymorphone. For oxycodone and/or oxymorphone screening, order Urine Oxycodone Screen (U OXY SCR, 8000708). PDM Changed

SEMEN EXAMINATION POST-VASECTOMY POSTVASEC Prep 89321 2002100 Semen Entire Ejaculate Plastic Screw Cap Abstain from sexual activity for at least 3 days before the specimen is collected. must be maintained at body temperature and submitted to the lab within 4 hours of collection. Post vasectomy must be noted on the Laboratory Request form. Completed specimen information form and specimen may be submitted between the hours of 7:00 AM - 9:00 PM. For specimen information forms, please call 805-7600. and specimen information form must be submitted to the lab within 4 hours of collection and maintained at body temperature. Maintain at body temperature (37 C) Body Temperature Microscopic examination of semen Reported as presence or absence of sperm Motility will be checked, if sperm present. SEMEN EXAMINATION POST-VASECTOMY POSTVASEC Prep 89321 2002100 Semen Entire Ejaculate Plastic Screw Cap Abstain from sexual activity for at least 3 days before the specimen is collected. must be maintained at body temperature and submitted to the lab within 4 hours of collection. Post vasectomy must be noted on the Laboratory Request form. Completed specimen information form and specimen may be submitted between the hours of 7:00 AM - 9:00 PM. For specimen information forms, please call 805-7600. must be submitted to the lab within 4 hours of collection and maintained at body temperature. Maintain at body temperature (37 C) Body Temperature Microscopic examination of semen Reported as presence or absence of sperm Motility will be checked, if sperm present. Ejaculates are centrifuged to improve the detection of sperm. Prep Changed Changed

VITAMIN D 25 HYDROXY VITD25OH Prep 82306 3503076 Vitamin D 25 Hydroxy (Cholecalciferol), Vitamin D3 1.5 ml SST or Red Top Tube to Plastic Transport Tube. Starting 4-16-12 only serum will be accepted. Direct Competitive Chemiluminescence Immunoassay (CLIA) 32-100 ng/ml; Recent studies consider the lower limit of 32.0 ng/ml to be a threshold for optimal health. Values of vitamin D vary with exposure to sunlight. There are also variations during the menstrual cycle, particularly at the time of ovulation. concentrations of 25-D are also known to vary with age, sex, race, season, and geographic location. VITAMIN D 25 HYDROXY VITD25OH Prep 82306 3503076 Vitamin D 25 Hydroxy (Cholecalciferol) 1.5 ml SST or Red Top Tube to Plastic Transport Tube. Starting 4-16-12 only serum will be accepted. Direct Competitive Chemiluminescence Immunoassay (CLIA) 32-100 ng/ml; Recent studies consider the lower limit of 32.0 ng/ml to be a threshold for optimal health. Values of vitamin D vary with exposure to sunlight. There are also variations during the menstrual cycle, particularly at the time of ovulation. concentrations of 25-D are also known to vary with age, sex, race, season, and geographic location. Changed

VOLATILES SCREEN VOLATILE Prep 84600 8000580 Methanol, Alcohol/ETOH, Acetone, Isopropyl 2.0 ml Red Top Tube or Dark Green Tube Do not use alcohol to cleanse arm to Plastic Transport Tube d Gas Liquid Chromatography Negative VOLATILES SCREEN Prep VOLATILE 84600 8000580 Methanol, Alcohol/ETOH, Acetone, Isopropyl 2.0 ml SST or Red Top Tube Do not use alcohol to cleanse arm to Plastic Transport Tube d Gas Liquid Chromatography Negative Toxic levels: Ethanol: >0.300 g/dl; Acetone: >50 mg/dl; Isopropanol: >10 mg/dl; Methanol: >20 mg/dl Toxic levels: Ethanol: >0.300 g/dl; Acetone: >50 mg/dl; Isopropanol: >10 mg/dl; Methanol: >20 mg/dl Changed